Vascular Receptor Autoantibodies in Pulmonary Arterial Hypertension Associated with Systemic Sclerosis
about
Update on biomarkers in systemic sclerosis: tools for diagnosis and treatmentFunctional autoantibodies in systemic sclerosis pathogenesis.Mechanisms of Autoantibody-Induced Pathology.Connective tissue disease-associated pulmonary arterial hypertension.The Effects of Antigen-Specific IgG1 Antibody for the Pulmonary-Hypertension-Phenotype and B Cells for Inflammation in Mice Exposed to Antigen and Fine Particles from Air Pollution.Associations between circulating endostatin levels and vascular organ damage in systemic sclerosis and mixed connective tissue disease: an observational study.Update in Pulmonary Vascular Diseases 2014.Influence of Endothelin-1 in Aqueous Humor on Intermediate-Term Trabeculectomy Outcomes.Functional autoantibodies in systemic sclerosis.Risk factors for severity and manifestations in systemic sclerosis and prediction of disease course.Recent Developments in the Classification, Evaluation, Pathophysiology, and Management of Scleroderma Renal Crisis.Current Approaches to the Treatment of Systemic-Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH).Recent advances in managing systemic sclerosis.Biomarkers in Scleroderma: Progressing from Association to Clinical Utility.Aberrant immune response with consequent vascular and connective tissue remodeling - causal to scleroderma and associated syndromes such as Raynaud phenomenon and other fibrosing syndromes?The Emerging Importance of Non-HLA Autoantibodies in Kidney Transplant Complications.Interstitial lung disease increases mortality in systemic sclerosis patients with pulmonary arterial hypertension without affecting hemodynamics and exercise capacity.Anti-angiotensin II type 1 receptor autoantibodies (AT1R-AAs) in patients with systemic sclerosis: lack of association with disease manifestations.Inflammation, Autoimmunity, and Hypertension: The Essential Role of Tissue Transglutaminase.Pathogenesis of systemic sclerosis-current concept and emerging treatments.An update on biomarker discovery and use in systemic sclerosis.Immediate and Catastrophic Antibody-Mediated Rejection in a Lung Transplant Recipient With Anti-Angiotensin II Receptor Type 1 and Anti-Endothelin-1 Receptor Type A Antibodies.The mast cell-B cell axis in lung vascular remodeling and pulmonary hypertension.C4d-negative antibody-mediated rejection with high anti-angiotensin II type I receptor antibodies in absence of donor-specific antibodies.Microvascular involvement in Systemic Sclerosis and Systemic Lupus Erythematosus.Immune cells and autoantibodies in pulmonary arterial hypertension.Functional autoantibodies targeting G protein-coupled receptors in rheumatic diseases.Anti-LG3 Antibodies Aggravate Renal Ischemia-Reperfusion Injury and Long-Term Renal Allograft Dysfunction.Circulating plasmablasts are elevated and produce pathogenic anti-endothelial cell autoantibodies in idiopathic pulmonary arterial hypertension.Autoantibodies in Serum of Systemic Scleroderma Patients: Peptide-Based Epitope Mapping Indicates Increased Binding to Cytoplasmic Domains of CXCR3.Inflammation and autoimmunity in pulmonary hypertension: is there a role for endothelial adhesion molecules? (2017 Grover Conference Series).Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis.Reply: vascular receptor autoantibodies in pulmonary arterial hypertension.Anti-Endothelin Receptor Type A Autoantibodies in Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension.Biomarkers for Pulmonary Vascular Remodeling in Systemic Sclerosis: A Pathophysiological Approach.
P2860
Q26995542-7CAD94C2-9ED7-4CF4-89E0-9DB24F174FC5Q33360501-4AB7A33F-7424-49DE-939B-06298C9950BDQ33740580-2F0106B1-D836-42C2-87ED-2030F6A200F3Q35029607-79606A2C-17F8-4383-9C47-C356A8527882Q35665034-AE2E59FA-2B59-4E32-AE1F-905AFF81DAD7Q36001528-E657A3DE-269F-4C7A-80D1-02736D1D51CAQ36128639-72639D89-56E7-4FDB-AFAD-9CBDFBB6145AQ38285517-895743EA-899F-4A5D-AA5C-139D06FDA1BAQ38570322-279F68B9-B866-44AF-9AD5-DEC92716B3FEQ38630663-F66CF520-75B1-4EF4-8F65-D31DA16871EDQ38681754-D8A9D6EE-8026-47C8-A465-8B2D4B305BAAQ38721897-4314F9F1-BD9D-4ACB-AB88-A298CADE5E38Q38759138-43D08C1F-41A8-47B1-8BFE-88D636A58D60Q38771824-7350D6C8-93CF-4D8F-9CF8-04CE46A36C5CQ38829051-76B46275-63FF-4B98-9A9E-BE2782ACB278Q38995184-F80B7BF0-B6FF-4B01-AA8D-E58795295A1CQ39061311-CECD24E2-3F57-4AC2-9089-3206EA4FF0DBQ39076219-F0833247-8BEB-49F9-98E5-B029F89B718AQ39198610-409B7A9F-424C-4ACE-A5DC-D4284C33BAEBQ39294794-DD35C21A-8AB8-4111-A94D-49800139E3A2Q39450087-20C2D487-FF46-405B-94BC-4B2EC173CD47Q44797161-45B2ABC7-E8A7-4BB0-B1BF-EBB638CBC5C7Q46175919-43A88F3B-622B-41C2-AA2B-BFEACA59EFCDQ47571875-D9C18C52-5F80-4ABA-B237-1C64F80C1899Q47660081-08D16462-9C93-48B4-8E79-B3D377970F44Q47742357-D3D79389-97F8-4B68-B543-946650BB34B7Q47880572-4FAD57BA-17A8-4707-A885-AE04B1EAE37EQ48055653-BB6A9E42-8D82-427F-82D5-3A5C84C256B3Q49711983-6A747C9C-4F36-419F-8389-982F5B290A40Q52603631-8DD95684-439E-4510-9D1F-4E03BE7D256EQ52685710-24F36C2F-0A48-4021-8A93-3CC38C28A71DQ52806995-00540990-A956-4037-92AC-C342FAF566B7Q52869246-D172D4BB-9959-43B7-8643-1F1045B23668Q53490347-30329232-918E-49F4-A0A9-DE5EF99D8661Q55499525-25338DB3-DF67-4E10-9184-D9BC086AE59D
P2860
Vascular Receptor Autoantibodies in Pulmonary Arterial Hypertension Associated with Systemic Sclerosis
description
im Oktober 2014 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 October 2014
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2014
@uk
name
Vascular Receptor Autoantibodi ...... ciated with Systemic Sclerosis
@en
Vascular Receptor Autoantibodi ...... ciated with Systemic Sclerosis
@nl
type
label
Vascular Receptor Autoantibodi ...... ciated with Systemic Sclerosis
@en
Vascular Receptor Autoantibodi ...... ciated with Systemic Sclerosis
@nl
prefLabel
Vascular Receptor Autoantibodi ...... ciated with Systemic Sclerosis
@en
Vascular Receptor Autoantibodi ...... ciated with Systemic Sclerosis
@nl
P2093
P2860
P50
P1476
Vascular receptor autoantibodi ...... ciated with systemic sclerosis
@en
P2093
Angela Kill
Angelika Rose
Anja A Kühl
Christoph Tabeling
Duska Dragun
Gabriela Riemekasten
Gerd R Burmester
Harald Heidecke
Henning Tiede
Ivo Lukitsch
P2860
P304
P356
10.1164/RCCM.201403-0442OC
P407
P577
2014-10-01T00:00:00Z